In this discussion, Jytte van Huijstee, Director of Clinical Trial Operations at myTomorrows, shares insights on technology’s role in...

In a recent interview, we spoke with Kari Brown, Chief Medical Officer, and Woody Bryan, Chief Executive Officer, from...

In this Q&A, we sit down with David Schaffer from SciTech Development to discuss the progress of their Phase...

We recently spoke with Simrit Parmar, MD, founder of Cellenkos, Inc. about their pioneering work in T-regulatory cell therapies....

A new report from ResearchAndMarkets.com analyzes the burgeoning cancer immunotherapy market, projecting its growth through 2029. The report examines...

Firefly Neuroscience (NASDAQ: AIFF) secured up to $12.4 million in financing, consisting of $2.4 million in convertible notes and...

SciSparc Ltd. (Nasdaq: SPRC) has renewed its approval from the Israeli Medical Cannabis Agency (IMCA) to continue its clinical...

Hutchmed is divesting its 45% stake in Shanghai Hutchison Pharmaceuticals Limited (SHPL) for approximately US$608 million to GP Health...

Verastem Oncology’s New Drug Application (NDA) for a combination therapy of avutometinib and defactinib, designed to treat recurrent low-grade...

RenovoRx (Nasdaq: RNXT) is bolstering its intellectual property (IP) portfolio with a new international patent application for its Trans-Arterial...